NRAS c.181_182delinsAC ;(p.Q61T)

Variant ID: 1-115256529-TG-GT

NM_002524.4(NRAS):c.181_182delinsAC;(p.Q61T)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.

Jama Oncology
Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM
Publication Date: 2021-04-01

Variant appearance in text: NRAS: Q61T
PubMed Link: 33630025
Variant Present in the following documents:
  • jamaoncol-e207987-s004.xlsx, sheet 2
View BVdb publication page



The genomic landscapes of individual melanocytes from human skin.

Nature
Tang, Jessica J; Fewings, Eleanor E; Chang, Darwin D; Zeng, Hanlin H; Liu, Shanshan S; Jorapur, Aparna A; Belote, Rachel L RL; McNeal, Andrew S AS; Tan, Tuyet M TM; Yeh, Iwei I; Arron, Sarah T ST; Judson-Torres, Robert L RL; Bastian, Boris C BC; Shain, A Hunter AH
Publication Date: 2020-10

Variant appearance in text: NRAS: Q61T
PubMed Link: 33029006
Variant Present in the following documents:
  • NIHMS1626314-supplement-1626314_SuppTable3.xlsx, sheet 2
View BVdb publication page



A Comparative Analysis of Individual RAS Mutations in Cancer Biology.

Frontiers In Oncology
Muñoz-Maldonado, Carmen C; Zimmer, Yitzhak Y; Medová, Michaela M
Publication Date: 2019

Variant appearance in text: NRAS: Q61T
PubMed Link: 31681616
Variant Present in the following documents:
  • fonc-09-01088.pdf
View BVdb publication page



Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.

Oncotarget
Lionetti, Marta M; Barbieri, Marzia M; Todoerti, Katia K; Agnelli, Luca L; Marzorati, Simona S; Fabris, Sonia S; Ciceri, Gabriella G; Galletti, Serena S; Milesi, Giulia G; Manzoni, Martina M; Mazzoni, Mara M; Greco, Angela A; Tonon, Giovanni G; Musto, Pellegrino P; Baldini, Luca L; Neri, Antonino A
Publication Date: 2015-09-15

Variant appearance in text: NRAS: Q61T
PubMed Link: 26090869
Variant Present in the following documents:
  • oncotarget-06-24205-s001.pdf
View BVdb publication page